Primer: Binhui Biopharmaceutical (BBP HK) - Apr 2026
Binhui Biopharmaceutical is a clinical-stage biotechnology company at the forefront of developing oncolytic virus immunotherapies, a promising...
107 Views
Pre-IPO Binhui Biopharmaceutical - The Success of Commercialization Is Highly Uncertain
Binhui's technological platform/CMC capability position it as a key player in oncolytic viruses,but commercial success is uncertain due to lack of...
403 Views
Binhui Biopharm (滨会生物) Pre-IPO Quick Take: High Innovation but Niche Indications
China's Binhui seeks to raise $100 million through Hong Kong listing with BS001 as its core product, using novel HSV-2 backbone. The company...
358 Views
ECM Weekly (27 October 2025)- Sany, Seres, PonyAI, WeRide, CIG, JST, Lenskart, Horizon, CRB
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
796 Views